

Two Philadelphia research teams just received millions in federal funding to develop one-dose gene therapies that could cure rare genetic diseases within five years.

The breakthrough approach uses AI and new delivery methods to create treatments that work for multiple patients instead of requiring custom therapy for each person.

Want to know more?